Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Anemia in oncology practice: relation to diseases and their therapies.

Tas F, Eralp Y, Basaran M, Sakar B, Alici S, Argon A, Bulutlar G, Camlica H, Aydiner A, Topuz E.

Am J Clin Oncol. 2002 Aug;25(4):371-9.

PMID:
12151968
2.

Tolerability of the cytoprotective agent amifostine in elderly patients receiving chemotherapy: a comparative study.

Genvresse I, Lange C, Schanz J, Schweigert M, Harder H, Possinger K, Sp├Ąth-Schwalbe E.

Anticancer Drugs. 2001 Apr;12(4):345-9.

PMID:
11335791
3.

The pharmacoeconomics of cancer therapies.

Bishop JF, Macarounas-Kirchman K.

Semin Oncol. 1997 Dec;24(6 Suppl 19):S19-106-S19-111. Review.

PMID:
9427279
4.
5.

Quantitative effect of combined chemotherapy and fractionated radiotherapy on the incidence of radiation-induced lung damage: a prospective clinical study.

Mah K, Keane TJ, Van Dyk J, Braban LE, Poon PY, Hao Y.

Int J Radiat Oncol Biol Phys. 1994 Feb 1;28(3):563-74.

PMID:
7509329
6.

Update in cancer chemotherapy, Part III: Lung cancer, Part 1.

Wright JC.

J Natl Med Assoc. 1985 Oct;77(10):815-27. Review.

Supplemental Content

Loading ...
Support Center